Because cancer won’t wait.
Because this fight needs the latest technology and most insightful answers. That’s why we created Oncomine Solutions, an integrated next-generation sequencing-based approach carefully designed for oncology labs—easy to implement and easy to use. Now any hospital can bring the power of Oncomine Solutions to their in-house laboratory, provide molecular insights to inform the most critical decisions, and realize the promise of precision oncology.
True precision oncology with in-house next-generation sequencing
Hear the latest about Oncomine Solutions
Upcoming Webinar
NTRK fusion testing in lung cancer – another reason to implement broad molecular profiling
With the emergence of a new class of targeted precision oncology therapies, NTRK fusions are increasingly becoming biomarkers that pathology laboratories can test for in FFPE tumor tissue. Although there are different testing options available such as IHC or FISH, NGS seems to be the preferred choice based on new guidelines. Register now to join us in discussing the pros and cons of different methods with the bigger picture in mind – the progress of precision oncology.
March 21, 2019
16:00 GMT/ 9:00am PDT / 12:00pm EDT
Precision oncology
Find out why next-generation sequencing is foundational for precision oncology
Oncomine Solutions
Get an integrated next-generation sequencing solution for oncology applications
Endeavor to improve patient outcomes
Discover how NGS is driving precision oncology to improve patient outcomes
Ready to learn more?
Ask our NGS Experts any questions you might have, or subscribe to get helpful updates from our team, including white papers, webinars, videos and more!
Trademarks | Terms and Conditions | Privacy Notices
© 2019 Thermo Fisher Scientific Inc. All Rights Reserved.
Select Your Location
United Kingdom
United States